Abstract
Fetal alcohol syndrome (FAS) is a pattern of anomalies occurring in children born to alcoholic women. The main features of this pattern are pre and/or postnatal growth retardation, characteristic facial abnormalities, and central nervous system dysfunction, including mental retardation. Since its clinical recognition in 1973 it has progressed from an unrecognized condition to a major public health concern with exaggerated and unfounded claims as to causality and impact. This review summarizes some of the basic facts about fetal alcohol syndrome with respect to terminology, prevalence, and mechanisms, in the context of exposure risk.
Keywords: Threshold, Risk Spectrum Terminology, Prevalence, Fetal Mechanisms, Alcohol Diagnosis, Abuse
Current Pharmaceutical Design
Title: Fetal Alcohol Syndrome: A Cautionary Note
Volume: 12 Issue: 12
Author(s): Ernest L. Abel
Affiliation:
Keywords: Threshold, Risk Spectrum Terminology, Prevalence, Fetal Mechanisms, Alcohol Diagnosis, Abuse
Abstract: Fetal alcohol syndrome (FAS) is a pattern of anomalies occurring in children born to alcoholic women. The main features of this pattern are pre and/or postnatal growth retardation, characteristic facial abnormalities, and central nervous system dysfunction, including mental retardation. Since its clinical recognition in 1973 it has progressed from an unrecognized condition to a major public health concern with exaggerated and unfounded claims as to causality and impact. This review summarizes some of the basic facts about fetal alcohol syndrome with respect to terminology, prevalence, and mechanisms, in the context of exposure risk.
Export Options
About this article
Cite this article as:
Abel L. Ernest, Fetal Alcohol Syndrome: A Cautionary Note, Current Pharmaceutical Design 2006; 12 (12) . https://dx.doi.org/10.2174/138161206776389886
DOI https://dx.doi.org/10.2174/138161206776389886 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mechanisms of Tumor Cell Necrosis
Current Pharmaceutical Design Patient-Controlled Analgesia
Current Drug Targets Chemotherapy and Cardiotoxicity in Hematologic Malignancies
Current Cancer Drug Targets Cerebrovascular Profile Assessment in Parkinson's Disease Patients
CNS & Neurological Disorders - Drug Targets Harnessing the Potential of Long Non-coding RNAs to Manage Metabolic Diseases
Current Pharmaceutical Design Regulation of Autophagy by Sphingolipids
Anti-Cancer Agents in Medicinal Chemistry Clinical and Imaging Findings in the Alveolar Echinococcosis
Current Medical Imaging Nutritional and Medical Applications of Spirulina Microalgae
Mini-Reviews in Medicinal Chemistry Pediatrics for Disability: A Comprehensive Approach to Children with Syndromic Psychomotor Delay
Current Pediatric Reviews Prospective Evaluation of the Dosing Regimen of Vancomycin in Children of Different Weight Categories
Current Drug Safety Calcium Related Genes in Dogs as Potential Cardiac Biomarkers for the Detection of Chronic Mitral Valve Disease
Recent Patents on Biomarkers Effects of Alcohol in the Lung
Current Respiratory Medicine Reviews Inhibitors for Metastasis Development
Recent Patents on Anti-Cancer Drug Discovery Editorial (Thematic Issue: Metabolic Disorders, Drug Development, Drug Design and Biomarkers)
Current Pharmaceutical Design Immune-Neuroendocrine Interactions Involving Thymus and Pineal Gland in Stem Cell Therapy of Age-Related Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Postoperative Care of the Transplanted Patient
Current Cardiology Reviews NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates
Anti-Cancer Agents in Medicinal Chemistry Nanotechnology for Nanomedicine and Delivery of Drugs
Current Pharmaceutical Design Strategies for Development of Antimalarials Based on Encapsulated Porphyrin Derivatives
Mini-Reviews in Medicinal Chemistry Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Current Pharmaceutical Design